Trials / Completed
CompletedNCT02985229
Acceptability and Feasibility of Medical Abortion in Singapore
Acceptability and Feasibility of Medical Abortion in Singapore: A Study of 800 μg Buccal Misoprostol Following 200 mg Mifepristone for Abortion Through 70 Days Gestation
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- Gynuity Health Projects · Academic / Other
- Sex
- Female
- Age
- 21 Years
- Healthy volunteers
- Accepted
Summary
To test the hypothesis that a regimen of 200 mg oral mifepristone, with the option of home administration, followed by 800 μg buccal misoprostol 24 hours later for abortion through 70 days LMP will be feasible and acceptable in Singapore.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mifepristone | The option of home or clinic administration of 200 mg oral mifepristone |
| DRUG | Misoprostol | 800 μg buccal misoprostol through 70 days LMP following administration of mifepristone |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2017-07-01
- Completion
- 2017-07-01
- First posted
- 2016-12-07
- Last updated
- 2018-04-06
Locations
2 sites across 1 country: Singapore
Source: ClinicalTrials.gov record NCT02985229. Inclusion in this directory is not an endorsement.